These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11220564)

  • 1. An abdominal active can defibrillator may facilitate a successful generator change when a lead failure is present.
    Solomon AJ; Moubarak JB; Drood JM; Tracy CM; Karasik PE
    Europace; 1999 Oct; 1(4):266-9. PubMed ID: 11220564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.
    Rashba EJ; Farasat M; Kirk MM; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):617-20. PubMed ID: 16836709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Implantable cardioverter/defibrillators with endocardial electrode systems: long-term stability of the defibrillator's effectiveness].
    Neuzner J; Pitschner HF; Stöhring R; Reinisch P; Schlepper M
    Z Kardiol; 1995 Jan; 84(1):44-50. PubMed ID: 7863713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel ventricular support device with defibrillation capabilities in canine and porcine animal models.
    Killingsworth CR; Rippy MK; Virmani R; Rollins DL; McGiffin DC; Ideker RE
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):851-7. PubMed ID: 18373602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system.
    Rashba EJ; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):790-4. PubMed ID: 15250864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The azygos defibrillator lead for elevated defibrillation thresholds: implant technique, lead stability, and patient series.
    Cooper JA; Latacha MP; Soto GE; Garmany RG; Gleva MJ; Chen J; Faddis MN; Smith TW
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1405-10. PubMed ID: 18950297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements.
    Schulte B; Sperzel J; Carlsson J; Schwarz T; Ehrlich W; Pitschner HF; Neuzner J
    Europace; 2001 Jul; 3(3):177-80. PubMed ID: 11467457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial and pleural lead ICD systems in children and adolescents maintain functionality over 5 years.
    Tomaske M; Prêtre R; Rahn M; Bauersfeld U
    Europace; 2008 Oct; 10(10):1152-6. PubMed ID: 18701602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?
    Osswald BR; De Simone R; Most S; Tochtermann U; Tanzeem A; Karck M
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):489-92. PubMed ID: 19144533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage of exposed implantable cardiac electrical devices and lead systems with pocket change and local flap coverage.
    Kolker AR; Redstone JS; Tutela JP
    Ann Plast Surg; 2007 Jul; 59(1):26-9; discussion 30. PubMed ID: 17589255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac defibrillation therapy for at risk patients with systemic right ventricular dysfunction secondary to atrial redirection surgery for dextro-transposition of the great arteries.
    Michael KA; Veldtman GR; Paisey JR; Yue AM; Robinson S; Allen S; Sunni NS; Kiesewetter C; Salmon T; Roberts PR; Morgan JM
    Europace; 2007 May; 9(5):281-4. PubMed ID: 17383987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of failure of transvenous implantable cardioverter-defibrillator leads.
    Borleffs CJ; van Erven L; van Bommel RJ; van der Velde ET; van der Wall EE; Bax JJ; Rosendaal FR; Schalij MJ
    Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):411-6. PubMed ID: 19808497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalent performance of epicardial versus endocardial permanent pacing in children: a single institution and manufacturer experience.
    Odim J; Suckow B; Saedi B; Laks H; Shannon K
    Ann Thorac Surg; 2008 Apr; 85(4):1412-6. PubMed ID: 18355537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel minimally invasive, intrapericardial implantable cardioverter defibrillator coil system: a useful approach to arrhythmia therapy in children.
    Hsia TY; Bradley SM; LaPage MJ; Whelan S; Saul JP; Ringewald JM; Reed JH
    Ann Thorac Surg; 2009 Apr; 87(4):1234-8; discussion 1238-9. PubMed ID: 19324158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
    Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ
    Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead interaction: rare cause of oversensing during implantation procedure of implantable cardioverter-defibrillator system.
    Gardas R; Mlynarski R; Staszak K; Drzewiecka A; Pilat E; Zajac T; Kargul W
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1174-5. PubMed ID: 17038149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explantation of implantable defibrillator leads using open heart surgery or percutaneous techniques.
    Camboni D; Wollmann CG; Löher A; Gradaus R; Scheld HH; Schmid C
    Ann Thorac Surg; 2008 Jan; 85(1):50-5. PubMed ID: 18154777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.